Role of genetic and expression profiling in pharmacogenomics: The changing face of patient management

Vincenzo Pagliarulo, Ram Datar, Richard J Cote

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

As the determination of gene sequences and their function gains speed at the dawn of the third millennium, biomedical research efforts are oriented towards definition of the genetic and molecular expression patterns that may drive different disease. A major part of these efforts is addressed to the definition of inter-individual variations that are expected to become integral for treatment planning, in terms of efficacy and adverse effects of drugs. It is this thrust on genome-based 'rational therapeutics' that is hoped to progressively lead to the era of 'personalized medicine'. This approach uses the technological expertise from genomics and functional genomics to define, predict and monitor the nature of the response of an individual to drugs, and to rationally design newer drugs. In the present review we will conduct our readers through an understanding of the fundamentals of pharmacogenomics and of the technologies currently available that are advancing this relatively new science. Conversely, there are issues raised that concern how medical practice is preparing itself to implement new alternatives for therapeutical interventions and finally, how to respect patient confidentiality and rights.

Original languageEnglish
Pages (from-to)101-110
Number of pages10
JournalCurrent Issues in Molecular Biology
Volume4
Issue number4
StatePublished - Oct 1 2002
Externally publishedYes

Fingerprint

Pharmacogenetics
Genomics
Precision Medicine
Drug Design
Confidentiality
Patient Rights
Pharmaceutical Preparations
Sequence Analysis
Biomedical Research
Molecular Biology
Genome
Technology
Therapeutics
Genes
Drive

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Role of genetic and expression profiling in pharmacogenomics : The changing face of patient management. / Pagliarulo, Vincenzo; Datar, Ram; Cote, Richard J.

In: Current Issues in Molecular Biology, Vol. 4, No. 4, 01.10.2002, p. 101-110.

Research output: Contribution to journalArticle

@article{0523394972ab4afabe2b24bd99e8fbd4,
title = "Role of genetic and expression profiling in pharmacogenomics: The changing face of patient management",
abstract = "As the determination of gene sequences and their function gains speed at the dawn of the third millennium, biomedical research efforts are oriented towards definition of the genetic and molecular expression patterns that may drive different disease. A major part of these efforts is addressed to the definition of inter-individual variations that are expected to become integral for treatment planning, in terms of efficacy and adverse effects of drugs. It is this thrust on genome-based 'rational therapeutics' that is hoped to progressively lead to the era of 'personalized medicine'. This approach uses the technological expertise from genomics and functional genomics to define, predict and monitor the nature of the response of an individual to drugs, and to rationally design newer drugs. In the present review we will conduct our readers through an understanding of the fundamentals of pharmacogenomics and of the technologies currently available that are advancing this relatively new science. Conversely, there are issues raised that concern how medical practice is preparing itself to implement new alternatives for therapeutical interventions and finally, how to respect patient confidentiality and rights.",
author = "Vincenzo Pagliarulo and Ram Datar and Cote, {Richard J}",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "4",
pages = "101--110",
journal = "Current Issues in Molecular Biology",
issn = "1467-3037",
publisher = "Caister Academic Press",
number = "4",

}

TY - JOUR

T1 - Role of genetic and expression profiling in pharmacogenomics

T2 - The changing face of patient management

AU - Pagliarulo, Vincenzo

AU - Datar, Ram

AU - Cote, Richard J

PY - 2002/10/1

Y1 - 2002/10/1

N2 - As the determination of gene sequences and their function gains speed at the dawn of the third millennium, biomedical research efforts are oriented towards definition of the genetic and molecular expression patterns that may drive different disease. A major part of these efforts is addressed to the definition of inter-individual variations that are expected to become integral for treatment planning, in terms of efficacy and adverse effects of drugs. It is this thrust on genome-based 'rational therapeutics' that is hoped to progressively lead to the era of 'personalized medicine'. This approach uses the technological expertise from genomics and functional genomics to define, predict and monitor the nature of the response of an individual to drugs, and to rationally design newer drugs. In the present review we will conduct our readers through an understanding of the fundamentals of pharmacogenomics and of the technologies currently available that are advancing this relatively new science. Conversely, there are issues raised that concern how medical practice is preparing itself to implement new alternatives for therapeutical interventions and finally, how to respect patient confidentiality and rights.

AB - As the determination of gene sequences and their function gains speed at the dawn of the third millennium, biomedical research efforts are oriented towards definition of the genetic and molecular expression patterns that may drive different disease. A major part of these efforts is addressed to the definition of inter-individual variations that are expected to become integral for treatment planning, in terms of efficacy and adverse effects of drugs. It is this thrust on genome-based 'rational therapeutics' that is hoped to progressively lead to the era of 'personalized medicine'. This approach uses the technological expertise from genomics and functional genomics to define, predict and monitor the nature of the response of an individual to drugs, and to rationally design newer drugs. In the present review we will conduct our readers through an understanding of the fundamentals of pharmacogenomics and of the technologies currently available that are advancing this relatively new science. Conversely, there are issues raised that concern how medical practice is preparing itself to implement new alternatives for therapeutical interventions and finally, how to respect patient confidentiality and rights.

UR - http://www.scopus.com/inward/record.url?scp=0036808725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036808725&partnerID=8YFLogxK

M3 - Article

C2 - 12432962

AN - SCOPUS:0036808725

VL - 4

SP - 101

EP - 110

JO - Current Issues in Molecular Biology

JF - Current Issues in Molecular Biology

SN - 1467-3037

IS - 4

ER -